A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-1764 ◽

2020 ◽

Vol 26 (20) ◽

pp. 5310-5319 ◽

Author(s):

Sara M. Tolaney ◽

Solmaz Sahebjam ◽

Emilie Le Rhun ◽

Thomas Bachelot ◽

Peter Kabos ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-0193 ◽

2021 ◽

Vol 27 (5) ◽

pp. 1582-1582

Author(s):

Sara M. Tolaney ◽

Solmaz Sahebjam ◽

Emilie Le Rhun ◽

Thomas Bachelot ◽

Peter Kabos ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Abstract P1-15-01: A randomized phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer: First results

10.1158/0008-5472.sabcs13-p1-15-01 ◽

2013 ◽

Author(s):

N Quenel-Tueux ◽

F Dalenc ◽

T Bachelot ◽

M Pulido ◽

H Bonnefoi ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Locally Advanced ◽

Hormone Receptor Positive ◽

Randomized Phase Ii ◽

First Results ◽

Positive Breast Cancer

Download Full-text

Abstract OT1-02-02: A phase II study of pembrolizumab in combination with palliative radiotherapy for metastatic hormone receptor positive breast cancer

10.1158/1538-7445.sabcs17-ot1-02-02 ◽

2018 ◽

Author(s):

R Barroso-Sousa ◽

H Gao ◽

WT Barry ◽

IE Krop ◽

JD Schoenfeld ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Palliative Radiotherapy ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

Cancer Medicine ◽

10.1002/cam4.164 ◽

2014 ◽

Vol 3 (2) ◽

pp. 293-299 ◽

Author(s):

Sara M. Tolaney ◽

Joon Jeong ◽

Hao Guo ◽

Jane Brock ◽

Daniel Morganstern ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Abstract OT3-05-10: A single arm phase II study of palbociclib in combination with tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer

10.1158/1538-7445.sabcs17-ot3-05-10 ◽

2018 ◽

Author(s):

OC Danciu ◽

K Hoskins ◽

D Tamkus ◽

C Truica ◽

A Blaes ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

First Line Therapy ◽

Hormone Receptor Positive ◽

Line Therapy ◽

Positive Breast Cancer

Download Full-text

Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.1065 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 1065-1065 ◽

Author(s):

Naoto T. Ueno ◽

Rie K. Tahara ◽

Babita Saigal ◽

Takeo Fujii ◽

James M. Reuben ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormonal Therapy ◽

Hormone Receptor ◽

Phase Ii Study ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Abstract P1-16-02: Phase II study of the feasibility and safety of radium-223 dichloride in combination with hormonal therapy and denosumab for the treatment of patients with hormone receptor-positive breast cancer with bone-dominant metastasis

10.1158/1538-7445.sabcs17-p1-16-02 ◽

2018 ◽

Author(s):

RK Tahara ◽

T Fujii ◽

B Saigal ◽

NK Ibrahim ◽

S Damodaran ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormonal Therapy ◽

Hormone Receptor ◽

Phase Ii Study ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

A phase II study in patients with hormone receptor positive breast cancer with bortezomib (Velcade®) in the reversal of endocrine resistance

http://isrctn.org/> ◽

10.1186/isrctn55808957 ◽

2012 ◽

Author(s):

Luc Dirix

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Endocrine Resistance ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

British Journal of Cancer ◽

10.1038/bjc.2015.247 ◽

2015 ◽

Vol 113 (4) ◽

pp. 585-594 ◽

Author(s):

Nathalie Quenel-Tueux ◽

Marc Debled ◽

Justine Rudewicz ◽

Gaetan MacGrogan ◽

Marina Pulido ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Locally Advanced ◽

Genomic Analysis ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.724195112.793501041 ◽

2014 ◽

Author(s):

Minesh Mehta ◽

Manmeet Ahluwalia

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Multicenter Phase ◽

Positive Breast Cancer

Download Full-text